Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

42
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
42
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

52
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
52
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

37
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
37

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Perioperative Outcomes and Complications of Laparoscopic Cholecystectomy in End-Stage Renal Disease Patients: A Prospective Comparative Study.

World journal of surgery·2026
Same author

PCI after SVG failure-native vessel or graft?

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Early outcomes and predictors of mortality in native aortic valve endocarditis: results from a national registry.

Open heart·2026
Same author

Mapping the academic landscape of PubMed-indexed cardiothoracic surgical research in India: a comprehensive bibliometric analysis.

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Stenting, surgery, or medical therapy alone in asymptomatic carotid artery stenosis? Interpreting the CREST-2 findings.

Indian journal of thoracic and cardiovascular surgery·2026
Same author

Aspirin monotherapy or DAPT after CABG in ACS? Insights from the TACSI Trial.

Indian journal of thoracic and cardiovascular surgery·2025

相关实验视频

Updated: Sep 10, 2025

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
04:48

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

Published on: November 28, 2018

8.0K

重温PARTNER 3试验:五年血动力学发现是否足以解决低风险大动脉狭窄的争论?

Pradeep Narayan1

  • 1Department of Cardiac Surgery, Rabindranath Tagore International Institute of Cardiac Sciences, Narayana Health, Kolkata, India.

Indian journal of thoracic and cardiovascular surgery
|August 27, 2025
PubMed
概括
此摘要是机器生成的。

在低风险患者中,通过导管的动脉置换显示出早期的益处,但与手术的动脉置换相比,长期存活率并不高. 对于年轻,低风险个体的治疗决定,长期存活至关重要.

关键词:
低风险的大动脉狭窄合作伙伴试验美国美国

更多相关视频

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.2K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.5K

相关实验视频

Last Updated: Sep 10, 2025

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
04:48

Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery

Published on: November 28, 2018

8.0K
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.2K
Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

27.5K

科学领域:

  • 心脏病学
  • 心血管外科
  • 医学成像

背景情况:

  • 在低手术风险患者中,PARTNER 3试验评估了跨导管主动脉置换 (TAVR) 与手术主动脉置换 (SAVR).
  • 心声检查结果评估了长期的门性能和患者的结果.

研究的目的:

  • 审查PARTNER 3试验的5年心声学数据.
  • 在低风险患者群体中比较TAVR和SAVR的长期结果.

主要方法:

  • 分析了PARTNER 3试验的5年心声检测结果.
  • 对晚期死亡率和患者存活率的相关出版物的审查.

主要成果:

  • TAVR早期显示出血液动力学的优势,包括改善右心室-肺动脉合和降低门动脉阻抗.
  • 这些早期的好处并不总是导致TAVR的优异长期结果.
  • 新出现的数据表明TAVR组的潜在晚期死亡率,早期结果与SAVR相似.

结论:

  • 在接受主动脉置换的年轻,低风险患者中,长期存活是指导治疗决策的关键因素.
  • 早期的血液动力学改善可能不会超过长期存活的重要性.
  • 治疗决策应优先考虑患者的持续生存,而不是短期的血液动力学指标.